Achieve Life Sciences (ACHV) Tops Q4 EPS by 5c

Achieve Life Sciences (NASDAQ: ACHV) reported Q4 EPS of ($0.26), $0.05 better than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Achieve Life Sciences (ACHV) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Goldman Sachs Downgrades Vonovia SE (VNA:DR) (VNNVF) to Neutral
• JPMorgan Downgrades Woolworths Holdings Ltd (WHL:SJ) to Underweight